Metropolitan Life Insurance CO Travere Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$7.18 - $9.82 $5,004 - $6,844	-697 Reduced 15.7%	3,743 $28,000
Q3 2023 Nov 14, 2023	BUY	$7.64 - $17.25 $3,491 - $7,883	457 Added 11.47%	4,440 $39,000
Q2 2023 Aug 10, 2023	BUY	$15.3 - $22.61 $7,512 - $11,101	491 Added 14.06%	3,983 $61,000
Q1 2023 May 15, 2023	SELL	$17.82 - $22.89 $5,613 - $7,210	-315 Reduced 8.27%	3,492 $78,000
Q4 2022 Jun 14, 2023	BUY	$18.47 - $26.14 $5,818 - $8,234	315 Added 9.02%	3,807 $80.1 Million
Q4 2022 Mar 30, 2023	BUY	$18.47 - $26.14 $4,285 - $6,064	232 Added 6.49%	3,807 $80,000
Q4 2022 Feb 15, 2023	BUY	$18.47 - $26.14 $4,285 - $6,064	232 Added 6.49%	3,807 $80,000
Q3 2022 Jun 14, 2023	BUY	$22.91 - $28.63 $1,901 - $2,376	83 Added 2.38%	3,575 $88.1 Million
Q3 2022 Mar 30, 2023	SELL	$22.91 - $28.63 $9,690 - $12,110	-423 Reduced 10.58%	3,575 $88,000
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $9,690 - $12,110	-423 Reduced 10.58%	3,575 $88,000
Q2 2022 Jun 20, 2023	BUY	$20.94 - $30.01 $10,595 - $15,185	506 Added 14.49%	3,998 $96,000
Q1 2022 Jun 20, 2023	BUY	$23.61 - $30.6 $11,946 - $15,483	506 Added 14.49%	3,998 $103,000
Q1 2022 Mar 30, 2023	SELL	$23.61 - $30.6 $294,534 - $381,735	-12,475 Reduced 75.73%	3,998 $103,000
Q1 2022 May 12, 2022	SELL	$23.61 - $30.6 $294,534 - $381,735	-12,475 Reduced 75.73%	3,998 $103,000
Q4 2021 Jun 21, 2023	BUY	$24.34 - $31.17 $315,957 - $404,617	12,981 Added 371.74%	16,473 $511,000
Q3 2021 Jun 21, 2023	BUY	$12.98 - $25.03 $168,493 - $324,914	12,981 Added 371.74%	16,473 $399,000
Q2 2021 Jun 21, 2023	BUY	$14.11 - $26.4 $183,161 - $342,698	12,981 Added 371.74%	16,473 $240,000
Q2 2021 Mar 30, 2023	BUY	$14.11 - $26.4 $11,654 - $21,806	826 Added 5.28%	16,473 $240,000
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $232,208 - $434,464	16,457 Added 102856.25%	16,473 $240,000
Q1 2021 Jun 26, 2023	BUY	$23.37 - $31.77 $284,062 - $386,164	12,155 Added 348.08%	15,647 $391 Million
Q1 2021 Mar 30, 2023	BUY	$23.37 - $31.77 $276,700 - $376,156	11,840 Added 311.01%	15,647 $390,000
Q1 2021 May 14, 2021	BUY	$23.37 - $31.77 $373 - $508	16 New	16 $391,000

Others Institutions Holding TVTX

# of Institutions

198

Shares Held

84.9M

Call Options Held

776K

Put Options Held

912K

Armistice Capital, LLC New York, NY

7.65M
Shares

$155 Million
1.78% of portfolio
Black Rock Inc. New York, NY

7.64M
Shares

$155 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.9M
Shares

$140 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

4.68M
Shares

$94.7 Million
2.23% of portfolio
Woodline Partners LP San Francisco, CA

4.34M
Shares

$87.8 Million
0.55% of portfolio

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account